287 related articles for article (PubMed ID: 23870202)
1. A systematic review of clinical trials of treatments for the congenital ichthyoses, excluding ichthyosis vulgaris.
Hernández-Martin A; Aranegui B; Martin-Santiago A; Garcia-Doval I
J Am Acad Dermatol; 2013 Oct; 69(4):544-549.e8. PubMed ID: 23870202
[TBL] [Abstract][Full Text] [Related]
2. Use of Topical Glycolic Acid Plus a Lovastatin-Cholesterol Combination Cream for the Treatment of Autosomal Recessive Congenital Ichthyoses.
Khalil S; Bardawil T; Saade S; Chedraoui A; Ramadan N; Hasbani DJ; Abbas O; Nemer G; Rubeiz N; Kurban M
JAMA Dermatol; 2018 Nov; 154(11):1320-1323. PubMed ID: 30208477
[TBL] [Abstract][Full Text] [Related]
3. Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study.
Verfaille CJ; Vanhoutte FP; Blanchet-Bardon C; van Steensel MA; Steijlen PM
Br J Dermatol; 2007 May; 156(5):965-73. PubMed ID: 17263800
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of topical 10% urea-based lotion in patients with ichthyosis vulgaris: a two-center, randomized, controlled, single-blind, right-vs.-left study in comparison with standard glycerol-based emollient cream.
Tadini G; Giustini S; Milani M
Curr Med Res Opin; 2011 Dec; 27(12):2279-84. PubMed ID: 22007909
[TBL] [Abstract][Full Text] [Related]
5. Inherited ichthyosis: Non-syndromic forms.
Takeichi T; Akiyama M
J Dermatol; 2016 Mar; 43(3):242-51. PubMed ID: 26945532
[TBL] [Abstract][Full Text] [Related]
6. Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial.
Vahlquist A; Blockhuys S; Steijlen P; van Rossem K; Didona B; Blanco D; Traupe H
Br J Dermatol; 2014 Jan; 170(1):173-81. PubMed ID: 24102348
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
Kragballe K; Steijlen PM; Ibsen HH; van de Kerkhof PC; Esmann J; Sorensen LH; Axelsen MB
Arch Dermatol; 1995 May; 131(5):556-60. PubMed ID: 7741542
[TBL] [Abstract][Full Text] [Related]
8. Effect of topical tazarotene in the treatment of congenital ichthyoses.
Hofmann B; Stege H; Ruzicka T; Lehmann P
Br J Dermatol; 1999 Oct; 141(4):642-6. PubMed ID: 10583110
[TBL] [Abstract][Full Text] [Related]
9. A case of harlequin ichthyosis treated with isotretinoin.
Chang LM; Reyes M
Dermatol Online J; 2014 Feb; 20(2):. PubMed ID: 24612573
[TBL] [Abstract][Full Text] [Related]
10. Retinoids in disorders of keratinization: their use in adults.
Happle R; van de Kerkhof PC; Traupe H
Dermatologica; 1987; 175 Suppl 1():107-24. PubMed ID: 2961628
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatments for cutaneous manifestations of inherited ichthyoses.
Cortés H; Del Prado-Audelo ML; Urbán-Morlán Z; Alcalá-Alcalá S; González-Torres M; Reyes-Hernández OD; González-Del Carmen M; Leyva-Gómez G
Arch Dermatol Res; 2020 May; 312(4):237-248. PubMed ID: 31624898
[TBL] [Abstract][Full Text] [Related]
12. Effective treatment of severe thermodysregulation by oral retinoids in a patient with recessive congenital lamellar ichthyosis.
Haenssle HA; Finkenrath A; Hausser I; Oji V; Traupe H; Hennies HC; Neumann C; Emmert S
Clin Exp Dermatol; 2008 Aug; 33(5):578-81. PubMed ID: 18355358
[TBL] [Abstract][Full Text] [Related]
13. Oral acitretin treatment in severe congenital ichthyosis of the neonate.
Saraçoğlu ZN; Tekin N; Urer SM; Sabuncu I; Akşit A
Turk J Pediatr; 2002; 44(1):61-4. PubMed ID: 11858383
[TBL] [Abstract][Full Text] [Related]
14. Severe ectropion in lamellar ichthyosis managed medically with oral acitretin.
Singh M; Kaur M; Kaur R; Singh S
Pediatr Dermatol; 2018 Mar; 35(2):e117-e120. PubMed ID: 29334142
[TBL] [Abstract][Full Text] [Related]
15. [Clinical presentation and etiology of ichthyoses. Overview of the new nomenclature and classification].
Oji V
Hautarzt; 2010 Oct; 61(10):891-902; quiz 903-4. PubMed ID: 20827455
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the clinical effect of topical tacalcitol on ichthyoses with retentive hyperkeratosis.
Okano M
Dermatology; 2001; 202(2):116-8. PubMed ID: 11306831
[TBL] [Abstract][Full Text] [Related]
17. Ichthyosis: etiology, diagnosis, and management.
DiGiovanna JJ; Robinson-Bostom L
Am J Clin Dermatol; 2003; 4(2):81-95. PubMed ID: 12553849
[TBL] [Abstract][Full Text] [Related]
18. Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosis.
Murrell DF; Teng JMC; Guenthner S; Marathe K; Kempers S; Eads K; Castelo-Soccio L; Mendelsohn AM; Raiz J; Bunick CG
Clin Exp Dermatol; 2023 Jun; 48(6):623-630. PubMed ID: 36794376
[TBL] [Abstract][Full Text] [Related]
19. Inherited Nonsyndromic Ichthyoses: An Update on Pathophysiology, Diagnosis and Treatment.
Vahlquist A; Fischer J; Törmä H
Am J Clin Dermatol; 2018 Feb; 19(1):51-66. PubMed ID: 28815464
[TBL] [Abstract][Full Text] [Related]
20. Congenital ichthyosis: an overview of current and emerging therapies.
Vahlquist A; Gånemo A; Virtanen M
Acta Derm Venereol; 2008; 88(1):4-14. PubMed ID: 18176742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
